Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Charlotte’s Web Holdings, Inc. is a U.S.-based wellness company focused on hemp-derived cannabidiol (CBD) products. The company develops, manufactures, distributes, and markets branded CBD wellness products used for sleep support, stress management, recovery, and general health applications. Charlotte’s Web operates primarily within the consumer wellness, nutraceutical, and hemp-derived botanical products industries. Its products include CBD oils, gummies, capsules, topical creams, functional mushroom blends, and pet wellness products sold under the Charlotte’s Web brand.
The company’s primary revenue drivers are direct-to-consumer e-commerce sales, retail distribution through health and wellness channels, and strategic retail partnerships. Charlotte’s Web is recognized for vertically integrated hemp cultivation and proprietary genetics associated with the “Charlotte’s Web” hemp strain, originally developed by the Stanley Brothers for pediatric epilepsy support. The company was founded in Colorado and became publicly traded in Canada in 2018. Its positioning has historically centered on brand recognition, product quality standards, broad retail distribution, and regulatory advocacy within the U.S. hemp-derived CBD market.
Business Operations
Charlotte’s Web generates revenue through the sale of hemp-derived wellness products across multiple categories. The company operates through integrated cultivation, extraction, manufacturing, marketing, and distribution activities. Its operations include owned and contracted hemp cultivation, proprietary extraction technologies, product formulation, and national distribution infrastructure. The company has historically emphasized compliance testing, quality assurance, and traceability as differentiators in a fragmented CBD market.
Operations are concentrated primarily in the United States, where the company distributes products through e-commerce channels, natural food retailers, pharmacies, and health-focused retail chains. Charlotte’s Web has maintained partnerships with major retail distributors and has expanded into functional wellness categories beyond CBD. The company also controls several intellectual property assets related to hemp genetics and formulations. Public filings and investor materials identify Abacus Health Products, Inc., acquired in 2020, as a significant strategic addition that expanded topical wellness capabilities and retail distribution relationships.
Strategic Position & Investments
Charlotte’s Web has focused its strategy on expanding brand leadership within regulated botanical wellness products while preparing for potential future U.S. federal CBD regulatory clarity. Growth initiatives have included broadening retail penetration, diversifying product categories, increasing direct-to-consumer engagement, and developing science-backed wellness formulations. The company has also invested in research partnerships related to hemp-derived cannabinoids and product efficacy.
A major strategic transaction was the acquisition of Abacus Health Products, Inc., which strengthened the company’s topical product portfolio and retail footprint. Charlotte’s Web has also pursued innovation in adjacent wellness sectors including adaptogens, functional mushrooms, and botanical supplements. The company has participated in industry advocacy efforts surrounding CBD regulation and quality standards. Public disclosures indicate continued investment in proprietary hemp genetics, cultivation efficiency, and vertically integrated production capabilities to support long-term margin improvement and brand differentiation.
Geographic Footprint
Charlotte’s Web is headquartered in Louisville, Colorado, and its core operational footprint is concentrated in the United States. The company has historically operated cultivation and production activities in states including Colorado and Kentucky, with retail and e-commerce distribution reaching customers nationwide. Its products are sold through thousands of retail locations across the U.S., including health food stores, pharmacies, and wellness retailers.
While the company’s primary commercial presence is domestic, Charlotte’s Web has pursued limited international opportunities where hemp-derived wellness products are permitted under local regulations. Publicly available filings indicate that international exposure remains relatively modest compared with its U.S. operations. The company’s market influence is strongest in the North American hemp-derived CBD sector, where it has maintained one of the more recognizable consumer wellness brands associated with hemp extracts.
Leadership & Governance
Charlotte’s Web was founded by the Stanley Brothers, whose development of the Charlotte’s Web hemp strain became foundational to the company’s identity and public recognition. The company’s leadership has emphasized science-based wellness products, regulatory engagement, vertical integration, and long-term consumer brand development within the hemp-derived wellness market.
Key executives and leadership figures include:
- Bill Morachnick – Chief Executive Officer
- Deanie Elsner – Former Chief Executive Officer and Director
- Jacques Tortoroli – Chief Financial Officer
- Jared Stanley – Co-Founder and Chairman
- Joel Stanley – Co-Founder
- Jesse Stanley – Co-Founder
The company operates under a board-led governance structure typical of publicly traded issuers and files regulatory disclosures through Canadian securities regulators and U.S. market reporting systems. Leadership communications in public filings and investor materials consistently emphasize disciplined brand management, regulatory preparedness, scientific validation, and operational efficiency as central strategic priorities.